Temple Health – Temple University Health System’s Post

Our new white paper examines the influence of age and disease type on reoperation rates following breast-conserving surgery, revealing higher reoperation rates in younger patients with a downward trend in rates with increasing age. Additionally, higher reoperation rates were observed for DCIS patients as compared to invasive breast cancer patients. Innovative strategies for margin assessment are needed to reduce reoperation rates, streamline workflow, and improve patient outcomes. Read more at https://bit.ly/3ZOhzZk. #breastcancerawareness #patientcare

Treatment of peritoneal surface malignancy has always presented a challenge, requiring a careful balance of eradicating or managing the cancer while minimizing morbidity.   In this latest Clinician’s View, AdventHealth Orlando Colorectal Surgeon and Surgical Oncologist Christopher Aquina, MD, MPH, explains how combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a safe and viable treatment option for certain patients with peritoneal carcinomatosis. This targeted approach is improving their outcomes, including both survival and quality of life. https://lnkd.in/eR2rgpHp

"SmartPAN makes pancreatic surgery more precise and closer to personalized therapy". DR. Thomas M. Pausch If you are wondering about the impact of SmartPAN on enhancing surgical practices and patient outcomes for pancreatic cancer! Check out the video below and learn more from DR. Thomas M. Pausch, MD From the Department of General, Visceral and Transplantation Surgery at Heidelberg University Hospital in Germany. Stay Tuned! #DiscoverLeaks #Detect_pancreatic_leakage #heidelberg #HeidelbergUniversityHospital #Innovation #CancerResearch #PancreaticCancerAwareness #InnovationInHealthcare #MedicalDevice #PancreaticSurgery #PancreaticFluidLeakage #SmartPAN #MaglePharmaCept #MagleGroup

Unveiling the layers of cancer! Join #YashodaTalksCancer for a deep dive into cancer symptoms, cutting-edge surgery options, and expert tips from leading specialists. Elevate your awareness all month long with #CancerAwareness by Yashoda Super Speciality Hospitals, Kaushambi. Stay tuned for invaluable insights! #CancerEducation #CancerSymptoms #CancerTreatment #ExpertTips #YashodaHospitalKaushambi

Did you know that the Complications from pancreatic leakage can reach up to 50% in certain cases? We asked PD Dr. med. Thomas M. Pausch, MD from the Department of General, Visceral and Transplantation Surgery at Heidelberg University Hospital about the complication rates from his experience, and he answered👇 Stay tuned as we unravel the complexities and raise awareness about the challenges in postoperative pancreatic cancer surgery. #DiscoverLeaks #Detect_pancreatic_leakage #Innovation #CancerResearch #PancreaticCancerAwareness #heidelberg #HeidelbergUniversityHospital #InnovationInHealthcare #SmartPAN #MaglePharmaCept #MagleGroup

❌ MYTH: Surgery is too aggressive for low-risk endometrial cancer. It always requires chemotherapy. ✅ FACT: As Dr Dmitry Utkin explains, surgery is still the most effective treatment for low-risk endometrial cancer. It plays a crucial role in accurate staging and high recovery rates. 💜🧡 #endometrialcancermyth #UterineCancer #endometrialcancer #wombcancer #patientcare #ENYGO

At Fred Hutch, we treat many rectal and anal cancers using #protontherapy. To treat GI tumors, physicians often use #radiationtherapy along with chemotherapy or surgery. This combination can be hard on patients, and some patients can’t have standard X-ray radiation therapy because it would cause too much harm to the healthy tissue near their tumor. For these patients, proton radiation therapy can be a good choice. It sends more radiation to the tumor with a goal of sending much less to nearby tissue and organs, which can limit side effects. Learn more here: https://bit.ly/3uPCcHC

Low-grade vs high-grade serous #OvarianCancer: comparison of surgical outcomes after secondary #CytoreductiveSurgery 🔍 https://bit.ly/3SuI54N High-grade and low-grade serous ovarian cancers each have a different presentation at time of recurrence. Therefore, secondary cytoreductive surgery in low-grade ovarian cancer is significantly more complex than its high-grade counterpart, while maintaining a similar rate of postoperative complications.

Insightful! Take a look at this video by DR. Thomas M. Pausch and see how SmartPAN could reduce post-op complications and make pancreatic surgery safer.

Different hospitals offer different outcomes for surgical patients. Listen and learn as experts discuss simulated outcomes of colorectal cancer surgery at the best local hospital versus chosen hospitals with JAMA Network Open. https://lnkd.in/gNWJCpBD